Contineum Therapeutics (CTNM) Other Non-Current Assets (2023 - 2026)

Contineum Therapeutics' Other Non-Current Assets history runs 4 years deep, the most recent figure standing at $312000.0 for Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 7700.0% year-over-year to $312000.0; the TTM figure through Mar 2026 stood at $312000.0 (up 7700.0% YoY), while the FY2025 annual figure was $256000.0, up 8433.33% from the prior year.
• Other Non-Current Assets was $312000.0 for Q1 2026 at Contineum Therapeutics, up from $256000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $2.6 million in Q1 2024 to a low of $3000.0 in Q2 2024.
• Historically, Other Non-Current Assets has averaged $493900.0 across 4 years, with a median of $221000.0 in 2025.
• Biggest YoY gain for Other Non-Current Assets was 8766.67% in 2025; the steepest drop was 99.85% in 2025.
• A 4-year view of Other Non-Current Assets shows it stood at $1.3 million in 2023, then sank by 99.77% to $3000.0 in 2024, then jumped by 8433.33% to $256000.0 in 2025, then grew by 21.88% to $312000.0 in 2026.
• The last three Other Non-Current Assets figures came in at $312000.0 (Q1 2026), $256000.0 (Q4 2025), and $266000.0 (Q3 2025), per Business Quant data.